The public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information.
Introduction 43
Campylobacter jejuni is one of the major causes of bacterial diarrhea 44 worldwide. The organism is unusual among enteric pathogens in that it 45 expresses a polysaccharide capsule (CPS) that contributes to serum resistance, 46 invasion of intestinal epithelial cells in vitro and virulence in ferret and Galleria 47 mellonella larvae models of disease (3, 8, 46 ). CPS is the major serodeterminant 48 of the Penner serotyping scheme of C. jejuni (27) of which there are 47 49 serotypes, a reflection of the diversity of polysaccharide capsular structures in C. 50
jejuni. In addition to variation in sugar composition, the CPS can be modified 51
with ethanolamine, glycerol and O-methyl phosphoramidate (MeOPN). The 52
MeOPN modification, which is found on about 75% of C. jejuni CPSs, has been 53 shown to modulate cytokine release from mouse dendritic cells and to be a key 54 determinant in virulence in the moth larvae model of disease (8). Both CPS 55 expression itself (3) and expression of the modifications are phase variable due 56 to slip strand mismatch repair (20, 28, 40) . Thus, reversible phase variations in 57 multiple genes result in mixed populations of wildtype cells, some of which 58 express CPS and others that do not (3). Similarly, the levels of the MeOPN 59 modifications found on the CPS are present in non-stoichiometric amounts 60 because of phase variation in genes encoding the enzymes involved in transfer 61 of these groups to specific sugars (37). 62
We have shown that a polysaccharide conjugate vaccine composed of the 63 capsule of strain 81-176 conjugated to carrier protein CRM197 showed 64 significant protection against diarrheal disease in a non-human primate model ofchloramphenicol resistance (Cm r ; cat) cassette, and the insertion points were 88 identified by sequencing individual insertions with primers within the cassette, as 89 previously described (11, 19, 26) . A clone with a non-polar insertion into gene 90 CJJ81176_1415 (mpnC in Fig. 1 Mouse infection experiments. Seven-to eight-week old BALB/c mice 116 (Jackson Laboratories, Bar Harbor, ME) were housed in groups of 10 with 117 access to food and water ad libitum. For infection with C. jejuni, one liter of broth 118 culture was harvested by centrifugation and resuspended in PBS. The inocula 119
were normalized by OD 600 to ~10 11 CFU/mL, and animals were inoculated 120 intragastrically with 100 μL of the cell suspension. The inocula doses were 121 validated on MH agar plates prior to and immediately after infection of the 122
animals. 123
Assessment of colonization. Fecal collections were performed by 124 allowing individual mice to defecate in clean, empty shoebox cages prior to 125 returning to group housing. Feces were collected using forceps into 5 mL Falcon 126 snap-cap tubes and then diluted 1:10 by weight into PBS. Various stool dilutions 127 were plated onto campylobacter selective media (CVA plates; Remel) and 128 incubated under microaerobic conditions at 42°C for 2 days. 129 Lymphocyte isolation. At indicated time points following oral challenge, 130 mice were sacrificed and small intestines were removed to recover lymphocytes 131 previously (32) with some modifications. In brief, Peyer's patches (PP) were 133 removed from the intestines and intestines were cleared of contents using 134 forceps, opened longitudinally and then cut into ~5mm sections. Intraepithelial 135 lymphocytes (IEL) were removed from these intestinal sections by placing the 136 tissue in a solution of 1 mM DTT/1 mM EDTA at 37°C for two 20 minute 137 incubations. After each incubation, the supernatant was removed and replaced 138 with fresh DTT/EDTA. To isolate LPLs, the remaining intestinal pieces were 139 digested with collagenase D (Roche, 1 mg/ml) and DNase I (Sigma, 40 µg/ml) for 140 two 1 h incubations at 37° C. The supernatant was removed following each 141 incubation and replaced with fresh media. Following the digestion of small 142 intestinal tissue sections, cells were pelleted by centrifugation and LPLs were 143 isolated using a discontinuous (80-40%) Percoll gradient. 144 Intracellular cytokine staining. LPL were cultured in vitro for 4-6 hours in 145 the presence of media alone or phorbol-12-myristate-13-acetate (PMA) (Sigma, 146 20 ng/ml) and ionomycin (Sigma, 0.5μg/ml). Media was DMEM supplemented 147 with 10% FBS, 2mM L-glutamine, 10 mM HEPES, 1 mM sodium pyruvate, non-148 essential amino acids, 50 µM 2-mercaptoethanol, penicillin (100 IU/ml) and 149 streptomycin (100 µg/ml). Protein transport was inhibited with the addition of 150 brefeldin A (10μg/ml). Following culture, LPLs were stained with CD4 APC. U/mL penicillin, 50ug/ml streptomycin, 100ug/ml Normocin (InvivoGen) and 1X 171 HEK-Blue selection (InvivoGen) in a 5% saturated CO 2 atmosphere at 37°C. 172
The THP1 cell line was maintained in standard RPMI 1640 medium with 10% 173 heat-inactivated fetal bovine serum (FBS) (Gibco) supplemented with 4.5 g/L 174 glucose, 2mM L-glutamine, 1.5 g/L sodium bicarbonate, 10mM HEPES, 1mM 175 sodium pyruvate, 50 U/mL penicillin, 50ug/ml streptomycin, 100ug/ml Normocin 176 (InvivoGen), 200ug/ml Zeocin (InvivoGen) and 250 ug/ml G418 (InvivoGen) in a 177 5% saturated CO 2 atmosphere at 37°C. to those published for 81-176 and its isogenic kpsM mutant (3) are shown in Fig.  228 2. Surprisingly, the mpnC mutant, expressing the polysaccharide CPS lacking 229
MeOPN, displayed the same pattern of serum killing as the kpsM mutant lacking 230 all CPS (Fig. 2) . The mpnC mutant was significantly more sensitive than wildtype 231 to complement at both 60 min (P <0.001) and 120 min (P<0.005). When the 232 mpnC mutant was complemented in trans, serum resistance returned to levels 233 comparable to wildtype (Fig. 2) . 234
Capsule is required for prolonged mouse colonization. The ability of 235 the kpsM and mpnC mutants to colonize mice was compared to wildtype in a 236 series of experiments. Animals were intragastrically infected with C. jejuni and 237 colonization was monitored post-infection by fecal shedding. Following infection, 238 wildtype C. jejuni 81-176 colonized mice on average at levels exceeding 10 6 239 CFU/g feces (Fig. 3A) . This high level of colonization was maintained for greater 240 than 15 days before counts began to drop below the initial colonization levels. 241
Mice infected with the kpsM mutant generally had early colonization levels similar 242 to that of wildtype (Fig. 3A) . In addition, the kpsM-infected mice had a shorter 243 duration of colonization compared to those infected with wildtype (P=0.06). The 244 majority of kpsM-infected mice cleared the infection by day 18 in comparison tothe wildtype-infected mice that remained colonized at some level through day 28 246 post-infection (the last day tested) (Fig. 3A) . Thus, despite the similar level of 247 colonization seen early post-infection, by day 14 there was a statistically 248 significant difference in colonization levels of mice infected with kpsM when 249 compared to wildtype (P <0.01). 250
In parallel experiments, colonization capacity of the mpnC mutant was 251 compared to wildtype. Upon infection with the mpnC mutant, mice shed similar 252 numbers of C. jejuni in their stool in comparison to wildtype (Fig. 3B) . In fact, 253
there were no significant differences in stool counts between the mpnC mutant 254 and wildtype during the first 10 days post-infection, and only later in infection did 255 the mpnC mutant demonstrate a significant reduction in the level of colonization 256 when compared to wildtype ( Fig. 3B; P=0 .02 for day 20). Thus, although not 257 directly compared, the colonization ability of the mpnC mutant appeared 258 intermediate in nature compared to wildtype and kpsM (Fig. 3) . 259
IL-17 expression from intestinal T cells is modulated by the 260 polysaccharide CPS. To determine if CPS had a role on immune responses in 261
vivo, mice were orally infected with wildtype 81-176 and mpnC or kpsM strains. 262
At selected times post-infection, T cells were isolated from small intestine Peyer's 263 patches, epithelium and lamina propria. Following an ex vivo restimulation, the 264 expression of IL-17 and IFN-γ were determined using intracellular cytokine 265 staining and flow cytometry. Figure 4A shows representative histograms for CD4 266
LPLs and dot plots demonstrating gating strategies for intracellular cytokine 267 staining (Fig. 4B ). Following infection with either kpsM or wildtype strains, CD4cells from the lamina propria of kpsM-infected mice exhibited significantly higher 269 percentages (P < 0.05) of CD4+ cells that expressed IL-17 at day 7 and day 21 270 (Fig 4C) . (Fig 4D) . 277
However, on day 21 post-infection, mice colonized by mpnC exhibited 278 significantly higher percentages (P < 0.01) of CD4+ LPLs expressing IL-17 than 279 animals infected with wildtype. In addition, no significant differences were seen 280 in other lymphocyte subsets or in IFN-γ expression patterns (data not shown). 281
Effects of CPS on TLR-signalling. To determine the impact of CPS 282 production and modification on TLR activation, we performed reporter cell 283 signaling assays with whole bacteria. The kpsM mutant exhibited significantly 284 higher activation than wildtype from 10 4 to 10 7 CFU for hTLR4 activation and from 285 10 5 -10 8 CFU for hTLR2 activation (Fig. 5) . Although similar results were seen 286 with the mpnC mutant, the lack of complete complementation confounds these 287
results (data not shown). 288
We subsequently compared the overall TLR-receptor activation of kpsM 289
and mpnC mutants using a human monocytic reporter line that expresses several 290 increases (P <0.005) in signaling were observed for both mutant strains 292 compared to wildtype and their complements (Fig. 6) . For the kpsM mutant 293 these differences were observed from 10 4 -10 7 CFU and for the mpnC mutant the 294 differences were observed between 10 5 -10 7 CFU. mpnA) compared to wildtype 81-176 was also reported in MyD88-defective mice 308 (54). In our studies BALB/c mice that were colonized with wildtype 81-176 309 remained colonized for the duration of the experiments (>21 days). The kpsM 310 mutant showed similar colonization levels for about 9 days before colonization 311 levels dropped. The mpnC mutant colonized at levels that were generally lower 312 than wildtype, although reaching statistical significance only at day 20. Thus, 313 expression of CPS by C. jejuni facilitated colonization in the mouse model. CPS 314 has also been shown to play a role in C. jejuni colonization of chickens (2, 16) . 315
Following restimulation, IL-17 production by CD4+ LPLs was reduced in 316 mice colonized by C. jejuni 81-176 compared to both mutant strains. Mice 317 colonized by either the kpsM or mpnC mutants possessed higher levels of IL-17+ 318 CD4+ cells in the small intestine compared to wildtype at day 21, and this 319 increased IL-17 production was associated with a reduction in colonization levels. 320
However, despite the fact that both the kpsM mutant and the mpnC mutant were 321 associated with higher frequencies of IL-17-producing CD4+ cells in the small 322 intestine compared to wildtype 81-176, the kpsM mutant appeared to show a 323 greater reduction in colonization capacity than the mpnC mutant suggesting that The % survivors are shown after 60 and 120 minutes incubation with 10% NHS. 686
The colors represent: black, 81-176; red, kpsM; green, mpnC; blue, mpnC 687 complemented in trans. 688 
